Implantable drug depots with external control of drug release which can replace repetitive injections.

M. Kraak
ETH Zurich - ETH transfer, CH

Keywords: Drug depot, biopharmaceuticals, drug implant, transdermal, patent life cycle management, galenic formulation, hydrogel, dose regulation, subcutaneous, intra muscular

Abstract:

The IP discloses a drug depot with embedded therapeutic substance that can be released in a dose-dependent way by the oral administration of a small molecule, an activator. The implanted drug depot may relief patients from repetitive injections and may lead to considerable improvement of their life.